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Abstract
Lattice degeneration of the retina is a vitreoretinal disorder characterized by a visible fundus lesion predisposing the patient
to retinal tears and detachment. The etiology of this degeneration is still uncertain, but it is likely that both genetic and
environmental factors play important roles in its development. To identify genetic susceptibility regions for lattice
degeneration of the retina, we performed a genome-wide association study (GWAS) using a dense panel of 23,465
microsatellite markers covering the entire human genome. This GWAS in a Japanese cohort (294 patients with lattice
degeneration and 294 controls) led to the identification of one microsatellite locus, D2S0276i, in the collagen type IV alpha 4
(COL4A4) gene on chromosome 2q36.3. To validate the significance of this observation, we evaluated the D2S0276i region
in the GWAS cohort and in an independent Japanese cohort (280 patients and 314 controls) using D2S0276i and 47 single
nucleotide polymorphisms covering the region. The strong associations were observed in D2S0276i and rs7558081 in the
COL4A4 gene (Pc=5.8610
26, OR=0.63 and Pc=1.0610
25, OR=0.69 in a total of 574 patients and 608 controls,
respectively). Our findings suggest that variants in the COL4A4 gene may contribute to the development of lattice
degeneration of the retina.
Citation: Meguro A, Ideta H, Ota M, Ito N, Ideta R, et al. (2012) Common Variants in the COL4A4 Gene Confer Susceptibility to Lattice Degeneration of the
Retina. PLoS ONE 7(6): e39300. doi:10.1371/journal.pone.0039300
Editor: Struan Frederick Airth Grant, The Children’s Hospital of Philadelphia, United States of Americs
Received January 24, 2012; Accepted May 17, 2012; Published June 19, 2012
Copyright:  2012 Meguro et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was supported by grants-in-aid for scientific research from the Japan Society for the Promotion of Science, grants-in-aid from the Ministry of
Education, Culture, Sports, Science and Technology of Japan (#16209052, N. Mizuki; #20592052, Y. Iijima; http://www.jsps.go.jp/english/). The funders had no
role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: mizunobu@med.yokohama-cu.ac.jp
Introduction
Lattice degeneration of the retina is a vitreoretinal disorder
characterized by a visible fundus lesion that predisposes the patient
to retinal tears and detachment. The prevalence of lattice
degeneration of the retina in the fellow eye of patients with retinal
detachments is estimated to be 35% [1]. Lattice degeneration is
characterized by sharply demarcated oval or round areas that are
oriented circumferentially and are associated with liquefaction of
the overlying vitreous gel and with firm vitreoretinal adhesions
along the edges of the lesions. Vitreous traction on these areas after
posterior vitreous detachment is often responsible for retinal tears.
Lesions clinically and histopathologically indistinguishable from
isolated lattice degeneration of the retina have been observed in
various hereditary disorders associated with retinal detachment.
The prevalence of lattice degeneration ranges from 6% to
nearly 11% in the general populations and reaches a maximum
during the second decade of life [2–4]. There is no statistically
significant difference in prevalence between men and women, and
left and right eyes are involved with equal frequency [2,3]. The
prevalence of lattice degeneration of the retina is not related to
race, and it has been reported to be common in Caucasians [2],
Asians [5,6], and Africans [7]. Although the etiology of familial
retinal detachment associated with lattice degeneration is thought
to be polygenic and/or multifactorial [8], the pathophysiological
mechanism and underlying genetic factors remain unknown.
In this study, we performed a genome-wide association study
(GWAS) using 23,465 microsatellite (MS) markers covering the
entire human genome to detect regions associated with suscepti-
bility to lattice degeneration of the retina. This MS set has




In order to reduce the type I error rate of this study, we carried
out three rounds of pooled DNA screening using three in-
dependent case-control populations containing the same number
of patients with essential lattice degeneration and normotensive
healthy individuals (stage 1, 100; stage 2, 100; stage 3, 94). In the
first screen, 2,898 markers had significantly different frequencies
between cases and controls; these 2,898 markers were further
analyzed in the second and third screenings using different sets of
cases and controls. After the second and third screenings, 173
markers remained positive with seven markers ascribed to six
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e39300distinct loci exhibiting similar peak patterns in the first, second,
and third case and control pools (Figure 1).
To confirm the associations detected for these seven markers,
we individually genotyped each marker in the same set of 588
screened individuals. Six of these seven markers showed statisti-
cally significant differences (P,0.05) after this individual screening
step; however, only one marker, D2S0276i, remained statistically
significant after correcting for multiple comparisons and displayed
a strong association with lattice degeneration of the retina
(P,2.1610
26, corrected P (Pc) ,1.9610
25; Table S1). We
validated this association in an independent Japanese cohort of
280 patients and 314 controls. Combined analysis in the two
cohorts revealed the strongest association (P,6.5610
27, Pc
,5.8610
26), and the allelic frequency of the 330-bp amplicon
of D2S0276i with 12 AAT repeats ([AAT]12) was decreased in
patients compared to controls (odds ratio (OR) =0.63; Table 1).
Single Nucleotide Polymorphism (SNP) Genotyping of
the D2S0276i Region
D2S0276i is located in the collagen type IV alpha 4 (COL4A4)
gene on chromosome 2q36.3 and its linkage disequilibrium. (LD)
appears to extend to the next gene, rhomboid domain containing 1
(RHBDD1). To dissect this region further, we selected a collection
of evenly spaced SNPs (coding and non-coding) covering 350 kb
around COL4A4 and RHBDD1. We genotyped samples from 1182
individuals (588 for the GWAS and 594 for replication) using
47 SNPs (Table 1, Table S2, Figure 2). Of these SNPs, 34 were
genotyped successfully, whereas 12 missense and 1 nonsense SNPs
turned out to be monomorphic. Among these 34 SNPs, nine
(rs4675115, rs4675124, rs4129886, rs3769641, rs3923084,
rs2229814, rs4389330, rs7558081, and rs6718820) exhibited an
association with lattice degeneration of the retina at P,0.05 in the
GWAS cohort. rs2229814, rs4389330 and rs7558081 showed
evidence of replication in the independent cohort. The strongest
association was observed at rs7558081 in the combined cohort
(P,6.9610
25, Pc,1.0610
25), and minor allele C of rs7558081
was decreased in patients compared to controls (OR=0.69).
Linkage Disequilibrium and Haplotype Analysis
Figure 2 shows the overall LD patterns for D2S0276i and the
34 SNPs genotyped successfully in 1182 individuals. Strong LD
was observed throughout the ,200-kb region including D2S0276i
and rs7558081 (from rs6752707 to rs7558081), and we therefore
identified this region as a candidate region for susceptibility to
lattice degeneration of the retina. D2S0276i exhibited a strong LD
with rs4389330 (D’=0.80), rs2229814 (D’=0.79) whereas LD
between D6S0276i and rs7558081 was a moderate level
(D’=0.44). rs7558081, rs4389330 and rs2229814 were in high
LD (D’.0.80).
To elucidate whether association of rs7558081, rs4389330 and
rs2229814 with the disease was due to LD with D2S0276i, we
stratified the patient and control populations according to the
presence of allele [AAT]12 of D2S0276i (Table 2). In 343 patients
and 301 controls lacking [AAT]12, only rs7558081 showed a weak
association with the disease (P=0.021, OR=0.77) whereas
rs4389330 and rs2229814 did not display significant associations
with the disease. Eleven haplotypes consisting of D2S0276i,
rs2229814, rs4389330 and rs7558081 were observed, and the
Figure 1. Flowchart of this genome-wide association study (GWAS) of lattice degeneration of the retina, with 23,465 microsatellite
(MS) markers.
doi:10.1371/journal.pone.0039300.g001
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GWAS of Lattice Degeneration of the Retina
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decreased in patients independent of the status of the rs2229814,
rs4389330 and rs7558081 alleles (Table 3).
Expression Analysis of COL4A4
D2S0276i is located in intron 41 of COL4A4. Since intronic
polymorphisms may significantly affect COL4A4 expression, we
investigated the association between the presence of D2S0276i
[AAT]12 and the level of COL4A4 expression using real-time
quantitative RT-PCR. The expression of COL4A4 mRNA
changed dependent on the presence of [AAT]12, but not
significantly, suggesting that [AAT]12 may affect expression levels
(Figure S1).
Discussion
Here we performed a GWAS of lattice degeneration of the
retina by multistep screening with 23,465 well-characterized MS
Figure 2. Association analysis of single nucleotide polymorphisms (SNPs) across the COL4A4 and RHBDD1 gene regions in 574
patients and 608 controls. The upper panels depict distribution of association results of D2S0276i and SNPs in COL4A4 and RHBDD1. The results of
monomorphic SNPs are not shown. The lower panels show the linkage disequilibrium structure in the COL4A4 and RHBDD1 regions; brighter red
indicates higher D’.
doi:10.1371/journal.pone.0039300.g002
Table 2. Allele frequencies of rs2229814, rs4389330 and








(n =301) P OR
rs2229814 A 65.8 63.6 0.40 1.10
rs4389330 C 63.6 59.1 0.094 1.21
rs7558081 C 37.3 43.8 0.021 0.77
OR, odds ratio.
P values were calculated by x
2 test 262 contingency table.
doi:10.1371/journal.pone.0039300.t002
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genome at average intervals of 115.1 kb; this investigation
identified COL4A4 as a novel candidate gene for lattice de-
generation of the retina. COL4A4 encodes the alpha 4 (IV) chain of
type IV collagen, a flexible protein. This chain combines with the
alpha 3 and alpha 5 chains to make a complete type IV collagen
molecule. Type IV collagen molecules attach to each other to form
complex protein networks that make up a large portion of the
basement membranes, thin sheet-like structures that separate and
support cells in many tissues.
Pathogenic features of lattice degeneration of retina include
liquefaction of the adjacent vitreous humor, absence of vitreor-
etinal attachments, absence of the internal limiting membrane
over the lesions, and vitreous condensation with a firm vitreor-
etinal attachment at the lesion margins. Pathogenesis may be due
to a developmental abnormality involving the internal limiting
membrane of the retina [15], which consists of the basal lamina of
Mu ¨ller’s cells and their basement membrane. Type IV collagen
alpha 3–5 networks play an especially important role in the
basement membranes of the kidney, inner ear, and eye [16];
COL4A4 mutations have been found to cause Alport syndrome
and thin basement membrane nephropathy [17–22]. Although the
pathogenesis of lattice degeneration of the retina remains poorly
understood, the basement membrane makes up a major retinal
structure. Vitreoretinal degeneration is complicated by retinal
detachment in Alport syndrome [23], leading us to speculate that
aberrations in COL4A4 may be involved in retinal thinning in cases
of lattice degeneration of the retina.
The strongest associations with the disease that we detected
occurred at D2S0276i in intron 41 and rs7558081 intron 20 of
COL4A4, and secondary signals were observed at rs4389330
(intron 20) and rs2229814 (exon 21), with the stratification and
haplotype analyses suggesting that the association with rs7558081,
rs4389330 and rs2229814 was due to LD with D2S0276i and was
not a primary association. Therefore, D2S0276i or its neighboring
polymorphism may be a causative factor for lattice degeneration of
the retina. To clarify the primary association, it will be necessary
to further explore the LD region of D2S0276i by a re-sequencing
analysis with D2S0276i [AAT]12-positive patients. Since intronic
polymorphisms can significantly affect gene expression, we
surmised that the disease-associated allele of D2S0276i [AAT]12
may regulate COL4A4 expression. However, we detected no
distinct association between [AAT]12 and gene expression in this
study although the expression levels observed in whole blood may
not reflect the levels in eye tissues.
This study is the first to comprehensively investigate suscepti-
bility genes for lattice degeneration of the retina. COL4A4 on
chromosome 2q36.3 was strongly associated with disease suscep-
tibility in the Japanese population, with allele [AAT]12 of
D2S0276i exhibiting the strongest association. To confirm our
findings, future validation studies with other ethnic populations are
needed and if the validation succeeds, [AAT]12 may serve as
a useful genetic marker for the diagnosis of lattice degeneration of
the retina. In addition, we could not demonstrate any functional
roles of COL4A4 polymorphisms in disease development. Thus,
functional studies are also required to clarify how COL4A4
polymorphisms contribute to the pathogenesis of lattice de-
generation of the retina.
Materials and Methods
Participants
A total of 574 unrelated patients with lattice degeneration of the
retina and 608 unrelated healthy controls, all of Japanese descent,
were enrolled in this study. The subjects were recruited from
Yokohama City University, Ideta Eye Hospital, Yonemoto Eye
Clinic, Nanbu Hospital, and Tokai University. Blood samples
were collected from the patients who were scheduled for surgery
for retinal detachment caused by lattice degeneration. Diagnosis of
lattice degeneration was made with indirect ophthalmoscopy and
scleral indentation by retina specialists via one or a combination of
the following inclusion criteria: the observation of lattice-like white
line changes in the crossing retinal vessels; the presence of snail-
track variations; alteration in pigmentation; the presence of ovoid
or linear reddish craters; localized round, oval, or linear retinal
thinning; attachment of condensed vitreous fibers to the edges of
the lesion. In spite of variations in pigmentation or other
morphological features, the lesion was regarded as lattice de-
generation when the examiner encountered an abrupt, discrete
irregularity of the otherwise smooth retinal surface at the borders
of the lesion. All control participants were healthy volunteers
unrelated to each other or to the patients. This study methodology
complied with the guidelines of the Declaration of Helsinki and
was approved by the ethics committees of Yokohama City
University, Ideta Eye Hospital, Yonemoto Eye Clinic, Nanbu
Hospital, and Tokai University. We obtained informed written
consent from all participants who donated DNA samples for this
analysis. Personal identities associated with medical information
and blood samples were eliminated and replaced with anonymous
identities at each recruiting institution.
Pooled DNA Construction
DNA pooling was performed as previously [24] with a slight
modification [25]. Genomic DNA was extracted from peripheral
blood lymphocytes using the QIAamp DNA Blood Maxi Kit
(QIAGEN) under standardized conditions. Following extraction,
DNA degradation and RNA contamination were assessed via
0.8% agarose gel electrophoresis; DNA was quantified using
a double-standard DNA quantification kit (PicoGreen, Molecular
Probes) as previously described [9,26]. To minimize pipetting
Table 3. Haplotype frequencies of D2S0276i, rs2229814,







(n =608) P OR
(D20276i, rs2229814, rs4389330 and rs7558081)
[AAT]10 : A : C : T 0.244 0.187 0.0011 1.39
[AAT]12 : G : G : C 0.164 0.231 2.6E-05 0.64
[AAT]14 : A : C : T 0.180 0.139 0.010 1.34
[AAT]10 : G : G : C 0.127 0.154 0.047 0.79
[AAT]13 : G : G : C 0.095 0.061 0.0024 1.60
[AAT]12 : G : G : T 0.047 0.056 0.30 0.82
[AAT]13 : A : C : T 0.048 0.039 0.32 1.23
[AAT]12 : A : C : T 0.019 0.029 0.11 0.65
[AAT]10 : A : G : C 0.014 0.029 0.012 0.47
[AAT]14 : G : G : C 0.014 0.015 0.77 0.90
[AAT]13 : A : C : C 0.009 0.011 0.50 0.76
OR, odds ratio.
Haplotypes with frequency less than 1% are not listed. P values were calculated
by x
2 test 262 contingency table.
doi:10.1371/journal.pone.0039300.t003
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technician using one set of calibrated pipettes. The concentration
of the genomic DNA samples was adjusted to 8 ng/ml and the
samples were divided equally into three case pools and three
control pools, with each pool containing equal numbers of men
and women. The pooled DNA template for MS typing was
prepared immediately by mixing equal numbers of patient and
control DNAs (100 at the first stage, 100 at the second stage, and
94 at the third stage). Multiple peak patterns from the pooled
DNA sample mirrored the distribution of allele frequencies in the
subject samples [24]. To confirm the suitability of pool DNA as
a time- and cost-saving alternative to individual DNA typing, we
compared the allelic distribution of three MS markers typed using
pooled vs. individual DNA (n=100). Allelic distributions were
assessed using Fisher’s exact test. No significant differences in allele
frequencies were found between pooled and individual DNAs,
thus validating this technique for large-scale use.
Genome-wide MS Genotyping
All MS markers and methods for MS genotyping used in this
study have been previously described [9]. PCR primers were
designed with a homogenous annealing temperature of 57uC.
Forward primers were labeled at the 59 end with the fluorescent
reagents 6-FAM or HEX (Applied Biosystems). PCRs of pooled
DNAs were performed in 20-ml reactions containing 24 ng of
pooled DNA, 0.5 U AmpliTaq Gold DNA polymerase (Applied
Biosystems), 2 ml1 0 6 reaction buffer (100 mM Tris-HCl
[pH 8.3], 500 mM KCl, 15 mM MgCl2), 2 ml dNTPs (2.5 mM
each), and 20 pmol of forward and reverse primers. The
amplification conditions consisted of initial denaturation at 96uC
for 9 min, annealing at 57uC for 1 min, and extension at 72uC for
1 min, followed by 30 cycles of denaturation at 96uC for 45 sec,
annealing at 57uC for 45 sec, and extension at 72uC for 1 min in
a GeneAmp PCR system 9700 thermal cycler (Applied Biosys-
tems). PCR of individual DNA was carried out in 20-ml reactions
containing 1 ng of genomic DNA, 0.5 U AmpliTaq Gold DNA
polymerase, 2 ml1 0 6reaction buffer, 2 ml dNTPs (2.5 mM each),
and 20 pmol of each primer. The amplification conditions were
essentially the same as described above except that 40 cycles were
used and a final extension of 5 min at 72uC was carried out after
40 cycles. The amplified products were denatured in formamide
(Hi-Di, Applied Biosystems) at 95uC for 3 min and separated on
a 3700 DNA analyzer (Applied Biosystems). Various data about
the markers, such as amplified peak positions and heights, were
manually extracted by the PickPeak and MultiPeaks programs
developed by Applied Biosystems Japan.
In the first screen with 100 cases and 100 controls, we employed
a total of 23,465 MS markers. Markers demonstrating a significant
association (P,0.05) with lattice degeneration of the retina were
subjected to a second screen of another set of 100 cases and 100
controls. Markers exhibiting a significant association in the second
screen were subjected to a third screen with another distinct 94
cases and 94 controls. The markers that tested positive in all three
screens were assessed for similar peak patterns in the first, second,
and third case and control pools; the identified markers were
subjected to the individual DNA screen and were genotyped in
588 individuals (the same 294 cases and 294 controls as mentioned
above). After the individual DNA screen, we tested the MS
D2S0276i, which showed a strong association with lattice de-
generation of the retina, in an independent Japanese cohort of 280
patients and 314 controls (Figure 1).
SNP Genotyping of the COL4A4 and RHBDD1 Gene
Regions
SNPs in the COL4A4 and RHBDD1 gene regions were selected
from HapMap Japanese data (MAF $20%, pairwise r
2$0.7,
PHWE $0.05). In addition, known non-synonymous SNPs in the
COL4A4 and RHBDD1 gene regions were also selected. Forty-
seven SNPs were selected and used to detect significant differences
between case and control samples (Table S2).
In this SNP genotyping to validate the MS-based GWAS results,
the GWAS cohort (the same 294 cases and 294 controls) and an
independent Japanese cohort (280 patients and 314 controls) were
used. SNP genotyping was performed using TaqManH SNP
Genotyping Assays according to the manufacturer’s instructions.
Reactions were carried out with the ABI GeneAmpH System 9700
thermal cycler and the ABI PRISMH 7900HT Sequence De-
tection System (Applied Biosystems) using a 384-well block module
for measuring fluorescence. SDS software version 2.0 was used for
allelic discrimination (Applied Biosystems). Ten nanograms of
genomic DNA were used as template for PCR amplification.
Real-time Quantitative RT-PCR
Whole blood (2.5 mL) was collected in PAXgene Blood RNA
tubes (Becton Dickinson) and gently mixed; tubes were incubated
at room temperature for 2 hours, and total RNA was extracted
using the PAXgene Blood RNA Kit (QIAGEN) according to the
manufacturer’s protocol. cDNA was synthesized using the Super-
Script
TM II Reverse Transcriptase (Invitrogen). Quantitative RT-
PCR of the COL4A4 gene was performed using the StepOne-
Plus
TM Real-Time PCR System (Applied Biosystems) with Taq-
Man gene expression assays (Assay ID: Hs01011885_m1, Applied
Biosystems), the THUNDERBIRD
TM Probe qPCR mix
(Toyobo), and ROX reference dye (Toyobo). COL4A4 expression
levels were normalized to those of 18S ribosomal RNA (Assay ID:
Hs99999901_s1, Applied Biosystems) for each individual.
Statistical Analysis
For MS genotyping, statistical significance of differences was
assessed by Fisher’s exact test using the 262 and 26m (where m is
the number of alleles) contingency tables for each allele. Allele
frequencies in pooled DNA stages were estimated from the height
of the peaks; each allele frequency was determined by dividing the
height of each allele peak by the summed height of all allele peaks.
For the exact probability test, the Markov chain/Monte Carlo
simulation method was employed to execute the Fisher’s exact test
for the 26m contingency table. The smallest P value for each
marker was selected. In the individual MS genotyping stage, the
probability of association was corrected by the Bonferroni’s
method, i.e. by multiplying the obtained P values with the number
of observed alleles at the locus (corrected P [Pc] value). Association
analyses for the SNP genotyping stage were carried out using
Haploview 4.1 [27] and obtained P values were corrected for
multiple testing by a permutation test (10,000 iterations) using
Haploview. Haploview 4.1 was also used to compute pairwise LD
statistics. Haplotype frequencies in the multi-locus analyses were
calculated using PyPop 0.7.0 [28]. Haplotype frequencies were
estimated using the iterative Expectation-Maximization algorithm.
LD was measured using Hedrick’s multiallelic D’ statistic [29].
Differences in COL4A4 mRNA expression levels were analyzed via
the Mann-Whitney U test.
GWAS of Lattice Degeneration of the Retina
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Figure S1 Expression analysis of COL4A4 mRNA strat-
ified by presence of D2S0276i [AAT]12. Bars represent mean
values and standard deviations of mRNA levels.
(PPT)
Table S1 Seven microsatellite markers used in the
individual DNA screening. OR, odds ratio. *Each allele was
named by the size of its amplification. P values were calculated by
x2 test 262 contingency table. These P values were corrected by
multiplying by the number of observed alleles at the locus (Pc
value).
(XLS)
Table S2 Allelic association results for D2S0276i and
47 SNPs in the COL4A4 and RHBDD1 gene regions. 1,
major allele; 2, minor allele; OR, odds ratio; SNP, single
nucleotide polymorphism. Position is distance from short arm
telomere. P values were calculated by x
2 test 262 contingency
table. We corrected P values (Pc) of D2S0276i and 47 SNPs in the
combined stage for multiple testing by Bonferroni’s method and
Haploview program using 10,000 permutations, respectively.
(XLS)
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